Our e-learning platform continues to expand and improve daily, and as of February 2025, we have reached 3393 users!

KSA has once again established itself as the undisputed leader among the top performers, with Poland and Romania retaining their respective second and third positions.
Congratulations to Qatar and the Russian Federation for their significant increase in users during 2024!

Discovering the most enrolled courses in EEMEA, it's exciting to see that the followings continue to captivate learners:

In terms of recently released trainings, it is definitely worth mentioning:
HEMOSTASIS
- Hemostasis Operator. Eight new operator training courses for HemoHub Intelligent Data Manager v1.9.1 (HHB191-02 to HHB191-09).
- Hemostasis Education/Anticoagulant Therapy. Monitoring and Reversal for Factor Xa Inhibitors (HEW83).
ACUTE CARE
- Acute Care Diagnostics Education/Patient Blood Management. Navigating Bleeding Management Guidelines from Global Regions: Practical Insights and Applications (ACW52).
- Acute Care Education/Patient Blood Management. Bleeding Management with Viscoelastic Testing (ACW51).
This Issue’s Featured NEW Course
- New Insights in Diagnosis and Treatment of Antiphospholipid Syndrome (HEW81).
This Werfen-sponsored ISTH webinar, with speakers Dr. Mary-Carmen Amigo and Scott Woller, provides a deep analysis of the 2023 ACR/EULAR Classification Criteria and explores the use of direct oral anticoagulants in APS treatment.
Key points:
- Classification Criteria are not diagnostic but help achieve homogeneous research populations.
- The 2023 ACR/EULAR Classification Criteria aim for higher specificity and include a total of 8 domains (6 clinical and 2 laboratory).
- The 2023 ACR/EULAR Classification Criteria also include an entry criterion to ensure only patients with minimal clinical and laboratory suspicion for APS are considered.
- Main concerns with the new Criteria are the exclusion of antibodies other than aPL/aB2GPI (such as aPS/PT or aD1) and the focus on ELISA, completely ignoring other automatized platforms.
- Clinical trials have shown mixed results for DOACs compared to VKAs, with warfarin remaining the first-line therapy for APS.
This webinar now includes Polish subtitles generated with Smartcat.
Introducing Smartcat
We're thrilled to introduce Smartcat, an all-in-one AI translation platform which helps delivering high-quality results. This platform provides automatic translations with near-human accuracy, significantly reducing the time needed to process large volumes of text.
Currently we are running a few pilot studies to test the platform, and the feedback has been fantastic. One project is already complete, with the addition of Polish subtitles to the HEW81 Course (see above). The second evaluation is underway, with the ambitious aim to translate all the ACL TOP 50 Series Operator trainings into Russian language. We can't wait to see the results!
We are sure this opportunity will enhance the overall Werfen Academy experience, helping us provide local language translations in a quick and efficient way. Curious to give it a try? Go ahead and contact us!
Looking forward to leverage more and more on Werfen Academy,
Werfen Academy Team



